Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, TEV-‘408 ...

Dr. Santos is board-certified by the American Board of Otolaryngology-Head and Neck Surgery and the American Board of Facial ...

SEATTLE — As the new year begins, aesthetic trends are shifting — and younger patients are leading the way. Doctors AJ Amadi ...

UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

A Vietnam war veteran was permanently disfigured by a dermatologist who failed to treat his skin cancer, a new $48 million ...

“Once the chamber reaches full pressure, guests breathe nearly pure oxygen, creating a deeply restorative environment.

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva's anti-IL-15 candidate TEV-'408TEV-' ...

Among patients with opioid overdose, bradycardia on initial vital signs was associated with a higher likelihood of xylazine ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...

Dr. Santos is board-certified by the American Board of Otolaryngology-Head and Neck Surgery and the American Board of Facial ...

The desire for a well-defined chin and a complementing jawline is nothing new. For years, implants were the go-to for ...